ROCKVILLE, MD, June 07, 2017 American Gene Technologies International Inc. (AGT), a genetic medicine company with a broad, robust lentiviral delivery platform, announced today that its CEO, Jeff Galvin, is presenting at the upcoming BIO International Convention. The Convention is being held on June… [Read More]

Rockville, Maryland, April 12, 2017 American Gene Technologies International Inc. (AGT), a genetic drug development company, announced the appointment of C. Neil Lyons as Executive Vice President and Chief Financial Officer.   Mr. Lyons joins AGT with over a decade of experience leading finance for clinical-stage,… [Read More]

Rockville, MD American Gene Technologies (AGT), a gene technology company with a broad, robust lentiviral delivery platform, announced today that the CEO, Jeff Galvin is presenting at the upcoming BIO CEO & Investor conference. The Conference is being held on February 13 -14, at the… [Read More]

ROCKVILLE, MARYLAND (October 4, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Dr. John J. Rossi, PhD as a collaborator on gene therapy research. Dr. Rossi is a leader in the field of molecular biology and a pioneer in the… [Read More]

ADDITION OF JONATHAN OTTERSTATTER SIGNALS ADDITIONAL MOMENTUM FOR GENE THERAPY PIONEERS ROCKVILLE, MARYLAND (May 24, 2016) – American Gene Technologies International, Inc. (AGT) today announced the appointment of Jonathan (Jon) Otterstatter to its board of directors. Otterstatter is co-founder, president and CEO of Preventice, Inc.,… [Read More]